Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost–utility analysis
Vaccination programs for RSV in some groups of older Canadians with underlying medical conditions are likely cost-effective. These findings can inform the design of vaccination programs.
Authors
- Winnie Siu (ORCID: https://orcid.org/0009-0001-5772-1509)
- Alison E. Simmons (ORCID: https://orcid.org/0000-0001-8780-9467)
- Alexandra Cernat (ORCID: https://orcid.org/0000-0001-6007-7825)
- Gebremedhin Beedemariam Gebretekle (ORCID: https://orcid.org/0000-0002-2485-505X)
- Matthew Tunis (ORCID: https://orcid.org/0000-0003-2092-9143)
- April Killikelly
- Man Wah Yeung
- Nicholas Brousseau (ORCID: https://orcid.org/0000-0001-6042-3177)
- Ashleigh R. Tuite (ORCID: https://orcid.org/0000-0002-4373-9337)
- Sarah A. Buchan (ORCID: https://orcid.org/0000-0002-5286-8974)
- Monica Rudd
Institutions
- Public Health Ontario (CA)
Publication Details
- Journal
- Canadian Medical Association Journal
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1503/cmaj.240452
- Citations
- 9
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 3.48